SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-021904
Filing Date
2020-11-18
Accepted
2020-11-18 08:55:33
Documents
23
Period of Report
2020-11-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39070
2 ex99-1.htm EX-99.1 30856
3 ex99-1_001.jpg GRAPHIC 4410
4 ex99-2.htm EX-99.2 6719
5 ex99-2_001.jpg GRAPHIC 88636
6 ex99-2_002.jpg GRAPHIC 199374
7 ex99-2_003.jpg GRAPHIC 100400
8 ex99-2_004.jpg GRAPHIC 137891
9 ex99-2_005.jpg GRAPHIC 147264
10 ex99-2_006.jpg GRAPHIC 121174
11 ex99-2_007.jpg GRAPHIC 114637
12 ex99-2_008.jpg GRAPHIC 73541
  Complete submission text file 0001493152-20-021904.txt   1619990

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE vbiv-20201118.xsd EX-101.SCH 3195
14 XBRL LABEL FILE vbiv-20201118_lab.xml EX-101.LAB 34591
15 XBRL PRESENTATION FILE vbiv-20201118_pre.xml EX-101.PRE 22716
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3599
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 201323184
SIC: 2834 Pharmaceutical Preparations